ArticleHuman cell2024

EP300 promotes tumor stemness via epigenetic activation of CRISP3 leading to lobaplatin resistance in triple-negative breast cancer.

Yan Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.